Skip to content
Head to head

Haemonetics vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: HAE · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

HAE +61.7%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories trades cheapest on trailing earnings; Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
HAEABT
Snapshot
SectorMedical DevicesMedical Devices
Last price120.16103.00
Change today-0.17%-0.84%
1-year return+60.0%-15.4%
Market cap$5.47B$178.39B
52-week range51.00 – 132.0080.89 – 126.70
Valuation
P/E (TTM)53.1738.29
P/E percentile, own 5-yr range78th99th
P/B6.093.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)2.053.72
Net profit (TTM)$93.35M$6.44B
Revenue (TTM)$1.38B$48.23B
Provider revenue period date2026-09-252026-09-29
Revenue growth (YoY)+9.3%+14.5%
Gross margin59.6%56.9%
Operating margin18.3%13.8%
Net margin7.5%9.7%
Free cash flow (TTM)$298.24M$6.76B
Provider cash-flow period date2026-09-252026-09-29
Ownership & sentiment
Institutional ownership108.0%81.2%
Insider activity (12mo)28 buy / 22 sell36 buy / 12 sell
Short interest (% of float)7.9%1.1%
Analyst consensus80% buy / 20% hold (10)93% buy / 7% hold (15)
Analyst price target$146 (+21%)$122 (+18%)
StockVane view
StockVane Quant RatingC (91)D (22)
Company
Employees3,009115,000
Founded19711900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.